Leukemia

IRF4 Gene Expression Associated With Development of Acute Myeloid Leukemia, Myelodysplastic Syndrome

By

Patricia Chaney

Publish Date September 15, 2021

Researchers sought to determine whether IRF4 expression is associated with an increased susceptibility to de novo AML and myelodysplastic syndrome.

Recommendations for Nurse Management of Immunotherapy-Induced Cytokine Release Syndrome in Pediatric Patients

By

Vicki Moore, PhD

Publish Date September 13, 2021

A systematic review identified nursing tips for the care of pediatric patients at risk of cytokine release syndrome after blinatumomab or CAR-T therapy.

How COVID-19 Lockdown Affected Outcomes of Acute Myeloid Leukemia Patients

By

Sucharita Mistry, PhD

Publish Date September 8, 2021

The mortality rate was significantly higher in the lockdown phase than in the lockdown-lifted phase.

Cause of Death Varies by Risk Group in Chronic Lymphocytic Leukemia

By

Sucharita Mistry, PhD

Publish Date September 8, 2021

For patients with low- or intermediate-risk disease, the risk of dying from CLL progression was similar to the risk of dying from CLL-related complications or from causes unrelated to CLL.

Most Hospitals Surveyed Did Not Have ‘Lifesaving’ Drug for Acute Promyelocytic Leukemia

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date September 1, 2021

Thirty-one percent of hospitals had ATRA immediately available.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .